Your browser doesn't support javascript.
loading
Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.
Sperl, Jan; Horvath, Gabor; Halota, Waldemar; Ruiz-Tapiador, Juan Arenas; Streinu-Cercel, Anca; Jancoriene, Ligita; Werling, Klara; Kileng, Hege; Koklu, Seyfettin; Gerstoft, Jan; Urbanek, Petr; Flisiak, Robert; Leiva, Rafael; Kazenaite, Edita; Prinzing, Renate; Patel, Sushma; Qiu, Jingjun; Asante-Appiah, Ernest; Wahl, Janice; Nguyen, Bach-Yen; Barr, Eliav; Platt, Heather L.
Affiliation
  • Sperl J; Institut Klinické a Experimentální Medicíny (IKEM), Prague, Czech Republic. Electronic address: jase@medicon.cz.
  • Horvath G; Budai Hepatólogiai Centrum, Budapest, Hungary.
  • Halota W; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Ruiz-Tapiador JA; Hospital Universitario Donostia, Gipuzkoa, Spain.
  • Streinu-Cercel A; Carol Davila University of Medicine and Pharmacy, National Institute for Infectious Diseases "Prof. Dr. Matei Balș", Bucharest, Romania.
  • Jancoriene L; Vilnius University, Department of Infectious and Chest Diseases, Dermatovenerology and Alergology, Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
  • Werling K; Semmelweis Egyetem, Budapest, Hungary.
  • Kileng H; UNN Universitetssykehuset Nord Norge, Tromsø, Norway.
  • Koklu S; Hacettepe University Medical Faculty, Ankara, Turkey.
  • Gerstoft J; Klinik for Infektionsmedicin, Rigshospitalet, University of Copenhagen, Denmark.
  • Urbanek P; Department of Internal Medicine, 1st Medical Faculty Charles University and Central Military Hospital, Prague, Czech Republic.
  • Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
  • Leiva R; Haukeland University Hospital, Bergen, Norway.
  • Kazenaite E; Vilnius University, Faculty of Medicine, Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
  • Prinzing R; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Patel S; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Qiu J; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Asante-Appiah E; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Wahl J; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Nguyen BY; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Barr E; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Platt HL; Merck & Co., Inc., Kenilworth, NJ, United States.
J Hepatol ; 65(6): 1112-1119, 2016 12.
Article in En | MEDLINE | ID: mdl-27542322
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C, Chronic Type of study: Clinical_trials Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2016 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C, Chronic Type of study: Clinical_trials Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2016 Document type: Article Country of publication: